483
Solaris Pharma CorpSolaris Pharma Corp – FDA 483, Sep 18, 2025
Record Details
Solaris Pharma Corp in Somerset, NJ, was inspected regarding its Periodic Adverse Drug Experience (PADE) reporting. The inspection revealed that the firm failed to submit several annual periodic adverse drug experience reports within the required 60-day timeframe. This indicates a lapse in timely regulatory compliance for drug safety reporting.
- Person
View Company Profile
ID · fe991640-a274-463f-a0eb-43b67bda9203
Other documents for Solaris Pharma Corp
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.